SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dauntless who wrote (3322)4/6/1998 9:07:00 AM
From: Hank  Read Replies (1) of 7041
 
SGP's statements in their annual report concerning Vasomax (ie that it is a an alternative to Viagra that will hopefully work on those that don't respond to Viagra) validates my hypothesis that SGP already knows Vasomax will not gain immediate approval without first conducting dual clinical trials to compare Vasmoax and Viagra. Approval is a long way away and hardly a sure thing.

Even my barber was asking me about Viagra this weekend. He's in his 60's and has had bypass surgery but doesn't take nitrates anymore. The word has spread pretty fast about this drug already.

Hank
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext